These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 36062048)
1. Heterotopic Transcatheter Tricuspid Valve Replacement in Severe Tricuspid Regurgitation and Refractory Right Heart Failure. Costa G; De Carlo M; Spontoni P; Giannini C; Angelillis M; Stazzoni L; Bozzoli D; Del Sorbo R; Petronio AS JACC Case Rep; 2022 Aug; 4(16):1005-1011. PubMed ID: 36062048 [TBL] [Abstract][Full Text] [Related]
2. Transcatheter Caval Valve Implantation of the Tricento Valve for Tricuspid Regurgitation Using Advanced Intraprocedural Imaging. Werner P; Russo M; Scherzer S; Aref T; Coti I; Mascherbauer J; Kocher A; Laufer G; Andreas M JACC Case Rep; 2019 Dec; 1(5):720-724. PubMed ID: 34316918 [TBL] [Abstract][Full Text] [Related]
3. An Experimental and Computational Study on the Effect of Caval Valved Stent Oversizing. Ismail M; Kumar GP; Kabinejadian F; Nguyen YN; Cui F; Tay EL; Leo HL Cardiovasc Eng Technol; 2016 Sep; 7(3):254-69. PubMed ID: 27357300 [TBL] [Abstract][Full Text] [Related]
4. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Lauten A; Ferrari M; Hekmat K; Pfeifer R; Dannberg G; Ragoschke-Schumm A; Figulla HR Eur Heart J; 2011 May; 32(10):1207-13. PubMed ID: 21300731 [TBL] [Abstract][Full Text] [Related]
5. Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial. O'Neill BP; Wheatley G; Bashir R; Edmundowicz D; O'Murchu B; O'Neill WW; Patil P; Chen A; Forfia P; Cohen HA Catheter Cardiovasc Interv; 2016 Aug; 88(2):287-93. PubMed ID: 27122473 [TBL] [Abstract][Full Text] [Related]
6. In Vitro Investigation of the Hemodynamics of Transcatheter Heterotopic Valves Implantation in the Cavo-Atrial Junction. Ismail M; Kabinejadian F; Nguyen YN; Tay E; Kim S; Leo HL Artif Organs; 2015 Sep; 39(9):803-14. PubMed ID: 25920812 [TBL] [Abstract][Full Text] [Related]
7. Transcatheter Caval Valve Implantation for Tricuspid Regurgitation After Single Leaflet Device Attachment. Rroku A; Barbieri F; Landmesser U; Skurk C; Kasner M; Reinthaler M JACC Case Rep; 2022 Apr; 4(8):481-485. PubMed ID: 35493801 [TBL] [Abstract][Full Text] [Related]
8. Heterotopic caval valve implantation in severe tricuspid regurgitation. Sharma NK; Chouhan NS; Bansal M; Chandra P; Singh A; Juneja R; Mehta Y; Trehan N Ann Card Anaesth; 2021; 24(3):365-368. PubMed ID: 34269270 [TBL] [Abstract][Full Text] [Related]
9. Interventional Treatment of Severe Tricuspid Regurgitation: Early Clinical Experience in a Multicenter, Observational, First-in-Man Study. Lauten A; Figulla HR; Unbehaun A; Fam N; Schofer J; Doenst T; Hausleiter J; Franz M; Jung C; Dreger H; Leistner D; Alushi B; Stundl A; Landmesser U; Falk V; Stangl K; Laule M Circ Cardiovasc Interv; 2018 Feb; 11(2):e006061. PubMed ID: 29445001 [TBL] [Abstract][Full Text] [Related]
10. Biomechanical performance of the Bicaval Transcatheter System for the treatment of severe tricuspid regurgitation. Crascì F; Cannata S; Gentile G; Gandolfo C; Pasta S Front Bioeng Biotechnol; 2023; 11():1179774. PubMed ID: 37274165 [No Abstract] [Full Text] [Related]
11. Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation. Rakita V; Lakhter V; Patil P; O'Neill BP Catheter Cardiovasc Interv; 2017 Sep; 90(3):521-525. PubMed ID: 28168785 [TBL] [Abstract][Full Text] [Related]